Your browser doesn't support javascript.
loading
Physical and cognitive impact following SARS-CoV-2 infection in a large population-based case-control study.
Holm, Hilma; Ivarsdottir, Erna V; Olafsdottir, Thorhildur; Thorolfsdottir, Rosa; Eythorsson, Elias; Norland, Kristjan; Gisladottir, Rosa; Jonsdottir, Gudrun; Unnsteinsdottir, Unnur; Sveinsdottir, Kristin E; Jonsson, Benedikt A; Andresdottir, Margret; Arnar, David O; Arnthorsson, Asgeir O; Birgisdottir, Kolbrún; Bjarnadottir, Kristbjorg; Bjarnadottir, Solveig; Bjornsdottir, Gyda; Einarsson, Gudmundur; Eiriksdottir, Berglind; Gardarsdottir, Elisabet Eir; Gislason, Thorarinn; Gottfredsson, Magnus; Gudmundsdottir, Steinunn; Gudmundsson, Julius; Gunnarsdottir, Kristbjorg; Helgadottir, Anna; Helgason, Dadi; Hinriksdottir, Ingibjorg; Ingvarsson, Ragnar F; Jonasdottir, Sigga S; Jonsdottir, Ingileif; Karlsdottir, Tekla H; Kristinsdottir, Anna M; Kristinsson, Sigurdur Yngvi; Kristjansdottir, Steinunn; Love, Thorvardur J; Ludviksdottir, Dora; Masson, Gisli; Norddahl, Gudmundur; Olafsdottir, Thorunn; Olafsson, Isleifur; Rafnar, Thorunn; Runolfsdottir, Hrafnhildur L; Saemundsdottir, Jona; Sigurbjornsson, Svanur; Sigurdardottir, Kristin; Sigurdsson, Engilbert; Sigurdsson, Martin I; Sigurdsson, Emil L.
Afiliación
  • Holm H; deCODE genetics/Amgen Inc., Reykjavik, Iceland. hilma.holm@decode.is.
  • Ivarsdottir EV; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Olafsdottir T; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Thorolfsdottir R; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Eythorsson E; Internal Medicine and Emergency Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
  • Norland K; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Gisladottir R; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Jonsdottir G; School of Humanities, University of Iceland, Reykjavik, Iceland.
  • Unnsteinsdottir U; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sveinsdottir KE; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Jonsson BA; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Andresdottir M; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Arnar DO; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Arnthorsson AO; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Birgisdottir K; Internal Medicine and Emergency Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
  • Bjarnadottir K; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Bjarnadottir S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Bjornsdottir G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Einarsson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Eiriksdottir B; Internal Medicine and Emergency Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
  • Gardarsdottir EE; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Gislason T; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Gottfredsson M; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Gudmundsdottir S; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Gudmundsson J; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Gunnarsdottir K; Internal Medicine and Emergency Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
  • Helgadottir A; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Helgason D; Internal Medicine and Emergency Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
  • Hinriksdottir I; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Ingvarsson RF; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Jonasdottir SS; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Jonsdottir I; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Karlsdottir TH; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Kristinsdottir AM; Internal Medicine and Emergency Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
  • Kristinsson SY; National Institute of Hearing and Speech in Iceland, Reykjavik, Iceland.
  • Kristjansdottir S; Internal Medicine and Emergency Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
  • Love TJ; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Ludviksdottir D; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Masson G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Norddahl G; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Olafsdottir T; Internal Medicine and Emergency Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
  • Olafsson I; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Rafnar T; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Runolfsdottir HL; Internal Medicine and Emergency Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
  • Saemundsdottir J; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Sigurbjornsson S; Internal Medicine and Emergency Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
  • Sigurdardottir K; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
  • Sigurdsson E; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sigurdsson MI; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
  • Sigurdsson EL; deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Commun Med (Lond) ; 3(1): 94, 2023 Jul 06.
Article en En | MEDLINE | ID: mdl-37414856
Persistent symptoms are commonly reported after SARS-CoV-2 infection, and this is often described as long Covid. We compared different symptoms reported following SARS-CoV- 2 infection with the results obtained during various medical evaluations that are often used to assess health, such as blood tests, smell tests, taste tests, hearing tests, etc. We compared symptoms and test results between 1,706 Icelanders who had been infected previously with SARS-CoV-2 infection (cases) and 14,398 individuals who had not been infected (controls). Out of 88 assessed symptoms, 41 were more common in cases than controls. However, relatively few differences were seen in the results obtained from the various medical evaluations (cases had poorer smell and taste test results, slightly less grip strength, and slightly poorer memory recall than controls). The differences seen between symptoms and results of medical evaluations suggests that conventional clinical tests may not be informative in relating symptoms to a past SARS-CoV-2 infection.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_transmissiveis Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Commun Med (Lond) Año: 2023 Tipo del documento: Article País de afiliación: Islandia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_transmissiveis Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Commun Med (Lond) Año: 2023 Tipo del documento: Article País de afiliación: Islandia
...